Several studies have shown that SGLT2i are associated with favourable CV and renal outcomes, by reducing the risks of death from CV causes, myocardial infarction, ischaemic stroke, HF hospitalizations, reduced renal function, end-stage renal disease, or death from renal causes, regardless of glucose control.1–4 This consistent evidence supports an early use of these drugs in patients with type 2 diabetes and high or very-high CV risk

The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending / Volpe, Massimo; Patrono, Carlo. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 42:15(2021), pp. 1458-1459. [10.1093/eurheartj/ehab136]

The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending

Volpe, Massimo;Patrono, Carlo
2021

Abstract

Several studies have shown that SGLT2i are associated with favourable CV and renal outcomes, by reducing the risks of death from CV causes, myocardial infarction, ischaemic stroke, HF hospitalizations, reduced renal function, end-stage renal disease, or death from renal causes, regardless of glucose control.1–4 This consistent evidence supports an early use of these drugs in patients with type 2 diabetes and high or very-high CV risk
2021
heart; cardiovascular; renal outcomes
01 Pubblicazione su rivista::01b Commento, Erratum, Replica e simili
The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending / Volpe, Massimo; Patrono, Carlo. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 42:15(2021), pp. 1458-1459. [10.1093/eurheartj/ehab136]
File allegati a questo prodotto
File Dimensione Formato  
Volpe_The-value_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 246.51 kB
Formato Adobe PDF
246.51 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1540987
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact